Massachusetts 2023-2024 Regular Session

Massachusetts Senate Bill S630

Introduced
2/16/23  
Refer
2/16/23  

Caption

Ensuring access to specialty medications

Impact

If enacted, this bill would amend existing laws in Chapter 112 of the General Laws. The licensing of specialty pharmacies and the mandated regulations surrounding their operation are expected to enhance the quality and safety of medication distribution. Furthermore, the bill stipulates that out-of-state pharmacies would not be allowed to dispense drugs within Massachusetts unless they obtain a specialty license, thus ensuring that all pharmacies meet the state’s regulatory standards.

Summary

Senate Bill S630, titled 'An Act ensuring access to specialty medications,' aims to establish a framework that regulates specialty pharmacies in the Commonwealth of Massachusetts. This legislation seeks to ensure that patients have better access to specialty medications, which are essential treatments often used to manage complex health conditions. The bill proposes that a 'specialty pharmacy' includes any pharmacy dispensing specialty drugs and requires these pharmacies to be licensed under specific procedures determined by the state board.

Contention

While proponents argue that this bill will significantly improve access to necessary medications for patients with complex medical needs, there may be concerns regarding the administrative burden it places on pharmacies. Critics may raise issues about the practical implications of compliance for smaller pharmacy operations and the potential for narrowed access if licensing requirements become overly burdensome. Additionally, some stakeholders might express apprehensions about how these regulations could impact insurance providers' requirements for specialty drug coverage.

Companion Bills

MA S1862

Similar To To eliminate the tax deduction for direct-to-consumer pharmaceutical marketing

MA H4634

Replaced by Study Order

Similar Bills

MA S665

Relative to specialty medications and patient safety

MA H1144

Relative to specialty medications and patient safety

MA S777

Relative to specialty medications and patient safety

LA SCR87

Requests the Louisiana Board of Pharmacy to study and make recommendations regarding the use of the terms "specialty drug" and "specialty pharmacy".

CA AB910

Pharmacy benefit management.

MD HB876

Health Insurance - Pharmacy Benefits Managers - Specialty Drugs

CA AB2348

Pharmacy benefit management.

MA H1322

Ensuring access to specialty medications